Covidien Surgical Device Sales Growth Of 10.5% Is Driven By Laparoscopy
This article was originally published in The Gray Sheet
Executive Summary
Newly independent medical technology firm Covidien's surgical device sales growth of 10.5% for the quarter ended June 29 was driven by demand for autosuture laparoscopic instruments in the United States and Europe, the company reported during its fiscal third-quarter earnings call Aug. 9
You may also be interested in...
Covidien Faces Challenge Of Accelerating Growth After Spin-Off From Tyco
Newly independent medical technology firm Covidien plans select acquisitions and divestitures as well as increased licensing activity to help accelerate growth following its June 29 spin-off from parent company Tyco International
Tyco Acquires Bio-Sealant Pipeline With $245 Mil. Confluent Surgical Buy
Tyco Healthcare subsidiary U.S. Surgical will acquire Confluent Surgical for $245 mil. to augment its suture business with a pipeline of bioabsorbable sealants
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.